nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A focus on the human lens in vitro
|
Wormstone, I. Michael |
|
2006 |
21 |
2 |
p. 215-221 7 p. |
artikel |
2 |
Can in vitro drug metabolism studies with human tissue replace in vivo animal studies?
|
Tingle, M.D. |
|
2006 |
21 |
2 |
p. 184-190 7 p. |
artikel |
3 |
Ex vivo cancer chemoprevention research possibilities
|
Hudson, E. Ann |
|
2006 |
21 |
2 |
p. 204-214 11 p. |
artikel |
4 |
Human-based alternatives to animal experiments: is ‘Replacement’ credible?
|
Vermeulen, Nico P.E. |
|
2006 |
21 |
2 |
p. 119- 1 p. |
artikel |
5 |
Inside front cover (Editorial board)
|
|
|
2006 |
21 |
2 |
p. CO2- 1 p. |
artikel |
6 |
In vitro and animal models of drug-induced blood dyscrasias
|
Ip, Julia |
|
2006 |
21 |
2 |
p. 135-140 6 p. |
artikel |
7 |
In vitro studies—how good are they at replacing in vivo studies for measurement of skin absorption?
|
Williams, Faith M. |
|
2006 |
21 |
2 |
p. 199-203 5 p. |
artikel |
8 |
Predicting oral drug absorption and hepatobiliary clearance: Human intestinal and hepatic in vitro cell models
|
Fearn, Richard A. |
|
2006 |
21 |
2 |
p. 168-178 11 p. |
artikel |
9 |
Progress in the development of in vitro human-based alternatives to animal models
|
Coleman, Michael D. |
|
2006 |
21 |
2 |
p. 120-122 3 p. |
artikel |
10 |
Structure and activity in assessing antioxidant activity in vitro and in vivo
|
Haenen, Guido R.M.M. |
|
2006 |
21 |
2 |
p. 191-198 8 p. |
artikel |
11 |
The merits of in vitro versus in vivo modeling in investigation of the immune system
|
Silliman, Christopher C. |
|
2006 |
21 |
2 |
p. 123-134 12 p. |
artikel |
12 |
The study of the pituitary gland using animals and alternatives: Can the latter completely replace the former?
|
Adams, Eric F. |
|
2006 |
21 |
2 |
p. 141-147 7 p. |
artikel |
13 |
The use of erythrocytic and animal models in the study of protein phosphorylation
|
Bordin, Luciana |
|
2006 |
21 |
2 |
p. 148-152 5 p. |
artikel |
14 |
The value of alternative testing for neurotoxicity in the context of regulatory needs
|
Coecke, Sandra |
|
2006 |
21 |
2 |
p. 153-167 15 p. |
artikel |
15 |
Utility of human/human-derived reagents in drug discovery and development: An industrial perspective
|
Hyland, Ruth |
|
2006 |
21 |
2 |
p. 179-183 5 p. |
artikel |